FDA-approved Drugs Selected Using Virtual Screening Bind Specifically to G-quadruplex DNA

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|12|2164-2173

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.12, 2013-04, pp. : 2164-2173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Public misconceptions about FDA-approved drugs

By  

Reactions Weekly, Vol. 1, Iss. 1372, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Pharmacogenomic characterization of US FDA-approved cytotoxic drugs

By Peters Eric J   Motsinger-Reif Alison   Havener Tammy M   Everitt Lorraine   Hardison Nicholas E   Watson Venita G   Wagner Michael   Richards Kristy L   Province Mike A   McLeod Howard L  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1407-1415

Future Medicine

Access to resources Recommend Favorite

In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens

By  

Current Pharmaceutical Design, Vol. 23, Iss. 14, 2017-05 ,pp. : 2147-2157

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress and Future Potential for Metal Complexes as Anticancer Drugs Targeting G-quadruplex DNA

By  

Current Medicinal Chemistry, Vol. 19, Iss. 18, 2012-06 ,pp. : 2957-2975

Bentham Science Publishers

Access to resources Recommend Favorite

Telomeric G-Quadruplex Architecture and Interactions with Potential Drugs

By  

Current Pharmaceutical Design, Vol. 20, Iss. 41, 2014-12 ,pp. : 6489-6509

Bentham Science Publishers

Access to resources Recommend Favorite